Company

RheumaGen

Biotechnology Research 200 Quebec St 6 employees

Employees: 6
Contacts: 3
Emails: 3
Phones: 1

www.rheumagen.com LinkedIn Crunchbase

RheumaGen Overview

Headquarters: 200 Quebec St
Website: www.rheumagen.com
Industry: Biotechnology Research
Employees: 6
Founded: 2019
Funding: 15.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Gene Therapy

About RheumaGen

RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.

RheumaGen Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage
Phone contacts: 1; 33.3% coverage

RheumaGen Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tate Hermanson	Director of Finance, Department of Medicine	Aurora, Colorado, United States	Email Phone
Brian Hart	Co-founder & COO - Rheumagen	Denver Metropolitan Area, United States	Email
Bruce Goodwin	Non-executive Director & Business Advisor Gaicd	Greater Sydney Area, Australia	Email